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Abstract
 
Lymph nodes (LNs) are important sentinal organs, populated by circulating lymphocytes and
antigen-bearing cells exiting the tissue beds. Although cellular and humoral immune responses
are induced in LNs by antigenic challenge, it is not known if LNs are essential for acquired im-
munity. We examined immune responses in mice that lack LNs due to genetic deletion of
lymphotoxin ligands or in utero blockade of membrane lymphotoxin. We report that LNs are
absolutely required for generating contact hypersensitivity, a T cell–dependent cellular immune
response induced by epicutaneous hapten. We show that the homing of epidermal Langerhans
cells in response to hapten application is specifically directed to LNs, providing a cellular basis
for this unique LN function. In contrast, the spleen cannot mediate contact hypersensitivity be-
cause antigen-bearing epidermal Langerhans cells do not access splenic white pulp. Finally, we
formally demonstrate that LNs provide a unique environment essential for generating this ac-
 
quired immune response by reversing the LN defect in lymphotoxin-
 
 
 
 
 
/
 
 
 
 mice, thereby re-
storing the capacity for contact hypersensitivity.
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Introduction
 
Secondary lymphoid organs are sites of immunological co-
ordination, where diverse cell types, including T cells, B
cells, APCs, and follicular dendritic cells (FDCs),
 
1
 
 are
brought together within a highly structured, organized en-
vironment. This organization has evolved to maximize an-
tigen presentation to the rare T cells capable of specific
TCR-mediated antigen recognition and clonal expansion,
and is considered necessary for the efficient development of
immune responses (1–3). Examples of secondary lymphoid
organs include the spleen, LNs, Peyer’s patches (PPs), mu-
cosa-associated lymphoid tissues (MALTs), and lymphocyte
aggregates such as the follicles and cryptopatches of the in-
testines and colon. These lymphoid compartments share
striking similarities in cellular organization, such as discrete
T and B cell areas, yet each also has unique, specialized
portals for cell or antigen entry, e.g., the afferent lymphat-
ics and high endothelial venules (HEVs) of LNs, the mar-
ginal zone (MZ) of the spleen, and the M cell–rich dome
of PPs. LNs are found throughout the body, yet despite in-
tensive investigation of the role of LNs in cellular and hu-
moral immune responses, it has not been demonstrated
whether these organs are absolutely required for any spe-
cific immune function.
In this study, we investigate whether LNs are required to
generate a T cell–dependent cellular immune response,
contact hypersensitivity (CH). It has been recognized for
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Abbreviations used in this paper:
 
 BM, bone marrow; CH, contact hy-
persensitivity; DC, dendritic cell; DNFB, dinitrofluorobenzene; ELC,
EBV-induced molecule 1 ligand chemokine; FDC, follicular dendritic
cell; LC, Langerhans cell; LT, lymphotoxin; mLN, mesenteric LN; MZ,
marginal zone; pLN, peripheral LN; 
 
plt
 
, paucity of LN T cells; PP,
Peyer’s patch; SLC, secondary lymphoid tissue chemokine; TMA, phe-
nyltrimethylammoaniline. 
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many years that efficient epidermal immune responses de-
pend on Langerhans cell (LC) uptake of antigen and traffic
to LNs (4, 5). However, studies directly addressing the role
of LNs in CH responses have used either physical disrup-
tion of LN lymphatic connections (6, 7), or agents capable
of blocking LCs or T cell access to LNs (8, 9), thereby iso-
lating antigen and responding cells. These studies showed
that the CH response is not primed in situ, i.e., in the skin
itself, and, along with the observation that LCs arrest in
draining LNs (10), suggested that LNs are sufficient to me-
diate CH responses. Although these data demonstrate a
correlation between LC traffic to LNs, intact lymphatic
vasculature, and CH reactions, it remains unclear if LNs are
the sole, and therefore essential, site where T cell priming
to epidermal antigens occurs. Therefore, we have devel-
oped novel model systems to test whether LNs are abso-
lutely required for CH responses.
Here we utilize lymphotoxin (LT)
 
 
 
 
 
/
 
 
 
 and LT
 
 
 
 
 
/
 
 
 
mice, which have developmental defects in LN genesis, to
study whether LNs are essential to generate a CH response.
Interaction of the membrane-bound, heteromeric ligand
LT
 
   
 
with its receptor (LT
 
 
 
-R) is a critical signal for the
genesis of LNs and PPs during embryonic development (3,
11, 12). The LT
 
 
 
 
 
/
 
 
 
 mouse is essentially devoid of LNs
and PPs (13, 14). The LT
 
 
 
 
 
/
 
 
 
 mouse has a similar pheno-
type; however, these mice can retain a subset of mucosa-
associated LNs (15, 16). LT gene–deficient mice thus pro-
vide potentially useful models for investigating the role of
LNs in various immune responses. However, the pheno-
types of these knockout mice include additional alterations
in the immune system (e.g., loss of the splenic MZ and of
FDC networks in spleen and LNs [3, 17–21]) which lead to
the disruption of splenic germinal center formation and Ab
responses (3). Therefore, we have employed in utero ma-
nipulation to induce LN formation in LT
 
 
 
 
 
/
 
 
 
 mice and to
block LN formation in wild-type mice (12, 22, 23), to cre-
ate model systems which allow us to determine if the ab-
sence of LNs, or the loss of LT ligand expression, impacts
the CH response. Our data clearly demonstrate that epider-
mal CH responses are not generated in the absence of LNs,
illustrating an essential role for LNs in this immune re-
sponse. The specific trafficking of LCs to LNs is shown to
provide a cellular basis for this unique LN function. These
results have important implications for our understanding
of LN function in local immunity and the trafficking of
LCs to different lymphoid compartments.
 
Materials and Methods
 
CH and LC Trafficking Studies.
 
All animal studies were per-
formed in accordance with Institutional Animal Care and Use
Committee standards. For LC trafficking studies, LT
 
 
 
 
 
/
 
 
 
, LT
 
 
 
 
 
/
 
 
 
,
LT
 
 
 
 
 
/
 
 
 
, or wild-type mice were painted on the shaved skin of
the upper back with 100 
 
 
 
l of 5 mg/ml FITC (Sigma-Aldrich)
dissolved in 50% acetone/50% dibutylphthalate (Sigma-Aldrich).
LNs were removed the next day for analysis of LC content by
FACS
 
®
 
 analysis and immunohistochemistry.
For CH experiments, dose response data were generated for
each hapten using wild-type Balb/c and C57Bl/6 mice. The
 
amount of hapten applied at both the sensitization phase and elic-
itation phase was titered to arrive at a dose that induced maximal
response without excessive hapten. This was done to reduce the
possibility that excess vehicle application could cause penetration
beyond the epidermis, or induce other unanticipated responses,
such as hapten tolerance (5, 24, 25). Mice were sensitized, rested
for 7 d, then rechallenged on the ear. Caliper measurements of
the ear were taken just before rechallenge and 24 h afterward,
and the data calculated as the percent increase in thickness. For
the hapten FITC, a dose of 100 
 
 
 
l of 5 mg/ml at sensitization
and 5 
 
 
 
l of 5 mg/ml at elicitation gave a maximal response. Us-
ing the hapten 4-ethoxymethylene-2-phenyl-2-oxazolin-5-one
(oxazalone) dissolved in ethanol, a dose of 100 
 
 
 
l of 0.3% at sen-
sitization and 10 
 
 
 
l 0.3% at elicitation was sufficient to elicit a
maximal response. For the dinitrofluorobenzene (DNFB) studies,
mice were painted on the shaved belly using 10 
 
 
 
l 1% solution in
vehicle (4:1 acetone/olive oil) followed by 10 
 
 
 
l on the footpad
5 d later, a protocol similar to those successfully used in several
recent studies (8, 9). Swelling of the footpad was measured after
24 h (challenged site 
 
 
 
 control site, in mm). Croton oil (ICN
Biomedicals) was diluted to 0.8% in acetone. 10 
 
 
 
l was applied to
each ear, and the swelling response was measured after 16 h. Phe-
nyltrimethylammoaniline (TMA) was obtained from Bachem
Inc. For experiments using TMA, mice were sensitized on the
shaved abdomen either by subcutaneous injection or skin paint-
ing with 50 
 
 
 
l of a 10 mM solution in saline (subcutaneous) or
DMSO (painting). Elicitation of the footpad was with 20 
 
 
 
l
TMA presented either subcutaneously or by painting. Footpad
swelling is measured as thickness at site of challenge 
 
 
 
 thickness
of contralateral control.
Adoptive transfer experiments were performed essentially as
described (9). In brief, Balb/c mice treated in utero with LT
 
 
 
-
R-Ig (see below) to ablate peripheral LN (pLN) and PP develop-
ment were sensitized with oxazalone. 4 d later the mesenteric LN
(mLN) and spleen were removed, and cells were isolated by me-
chanical disruption and red blood cell lysis. mLN cells isolated
from untreated Balb/c mice were used as a negative control.
2.5 
 
 
 
 10
 
7
 
 isolated cells were injected intravenously into normal,
naive, syngeneic recipients, which were immediately challenged
by ear painting with oxazalone. 24 h later the percent increase in
ear swelling was measured. The results were compared with the
CH response induced using the normal challenge/sensitization
regimen.
In all experiments, mice were housed individually to prevent
grooming of the sensitized area of the skin. All mice were coded
and were measured in random order. Statistical significance of the
change in ear thickness was determined using tests of the equiva-
lence of the means.
 
Irradiation and Bone Marrow Transfer.
 
LT
 
 
 
 
 
/
 
 
 
 and LT
 
 
 
 
 
/
 
 
 
mice were lethally irradiated using 1,100 rad (Gamma cell; Nor-
dion International Inc.) and reconstituted within 4 h with 2 
 
 
 
10
 
6
 
 bone marrow (BM) cells derived from the donor mice. The
BM cell suspension was subjected to depletion using anti-Thy1.2
and rabbit complement (Accurate Chemical & Scientific Corp.)
before use to remove mature T cells. After reconstitution, 
 
 
 
5%
of hemopoietic cells were recipient derived.
 
LN Induction and Ablation Protocols.
 
To generate peripheral
and mucosal LNs in the progeny, pregnant female LT
 
 
 
 
 
/
 
 
 
 mice
were injected with 250 
 
 
 
g of agonist anti–LT
 
 
 
-R mAb AF.H6
via the tail vein beginning on gestation day 11 or 12, followed by
additional injections intravenously every 48 h, as described (12).
Other pregnant LT
 
 
 
 
 
/
 
 
 
 mice were treated with control hamster
mAb Ha4/8 (anti-KLH). To ablate LN development, pregnant 
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female Balb/c or C57Bl/6 mice were injected intravenously mul-
tiple times with 100 
 
 
 
g of purified murine LT
 
 
 
-R-Ig, 100 
 
 
 
g
TNF-R55-Ig, or both together, as described (12). The presence
or absence of LNs was carefully determined by dissection of rep-
resentative progeny of each litter, and confirmed in each individ-
ual animal at necropsy.
 
Immunohistochemistry and FACS
 
®
 
 Analysis.
 
Mouse spleen and
LNs were harvested, frozen, sectioned, and stained for B220 and
CD11c as described previously (22, 23). Trafficking of LCs to
LNs was analyzed by UV induced fluorescence of the captured
FITC, in combination with PE-coupled anti-B220 mAb (BD
PharMingen). All sections were viewed under 50
 
 
 
 or 100
 
 
 
 op-
tics and captured as digitized image files using either single or
dual filters. The images shown are representative of those ob-
tained from a minimum of four animals per treatment group from
a minimum of four independent experiments. The identity of
FITC-laden LCs in LNs was confirmed using FACS
 
®
 
 analysis and
CELLQuest™ software (Becton Dickinson).
 
Results
 
LT
 
 
 
 
 
/
 
 
 
 Mice Cannot Mount a CH Response to Haptens.
 
Immunohistochemical staining revealed that the distribution
of LCs in the skin of LT
 
 
 
 
 
/
 
 
 
 mice was essentially indistin-
guishable from wild-type mice (unpublished data). There-
fore, we tested if these LCs were capable of supporting CH
responses in the absence of LNs. We first established dose
response curves for the response of wild-type mice to the
haptens FITC and oxazalone (Table I) and confirmed that
our established doses were within the linear portion of the
 
Table I.
 
Titration of the Hapten Doses Used in CH Experiments
 
Hapten
Sensitization
dose
Elicitation
dose
CH
response
 
*
 
FITC-isothiocyanate Fixed concentration
 
‡
 
 (
 
 
 
l)
200 10 65 
 
  
 
17
100 10 100 
 
  
 
26
50 10 39 
 
  
 
21
25 10 20 
 
  
 
15
01 0 0  
 
  
 
6
Oxazalone Fixed volume
 
§
 
 (%)
1.0 0.3 109 
 
  
 
7
0.3 0.3 107 
 
  
 
31
0.3 0.1 93 
 
  
 
27
0.1 0.1 79 
 
  
 
23
0 0.3 12 
 
  
 
12
Mice were shaved and painted on the upper trunk with the indicated
doses of hapten.
 
*
 
5 (oxazalone) or 10 (FITC) d later mice were rechallenged on the
ears, and the percent increase in the thickness of the ears was measured
after 24 h.
 
‡
 
For FITC experiments, a concentration of 5 mg/ml was used, and the
volume was varied.
 
§
 
For oxazalone experiments, fixed volumes of 150 
 
 
 
l at sensitization and
10 
 
 
 
l at elicitation were used, and the concentration of hapten was varied.
 
Table II.
 
LT
 
 
 
 
 
/
 
 
 
 Mice Cannot Mount a CH Response to Secondary Hapten Challenge but Retain a Sensitivity Response to Hapten 
Presented Subcutaneously
 
CH responses Subcutaneous and CH responses to TMA
Strain Sensitization Elicitation
Swelling
(%) Strain
 
n
 
Priming dose
and route
Swelling
(mm)
LT
 
 
 
/
 
 
 
FITC Vehicle 9 
 
  3* LT  /  5 10 mm, 50  l s.c. 0.90   0.23
LT /  FITC FITC 61   8L T   /  6 10 mm, 50  l s.c. 0.70   0.12
LT  /  FITC FITC 16   8* Control 3 0 0.18   0.02
LT /  Vehicle 0.3% oxazalone 5   8.5* LT  /  5 10 mm, 50  l e.c. 0.68   0.16
LT /  0.3% oxazalone 0.3% oxazalone 31.6   13.6 LT  /  6 10 mm, 50  l e.c. 0.28   0.11‡
LT  /  0.3% oxazalone 0.3% oxazalone 5.1   4.3* Control 3 0 0.10   0.03
LT /  2% oxazalone 0.3% oxazalone 40   22
LT  /  2% oxazalone 0.3% oxazalone 4.7   6.1*
LT /  None 0.8% croton oil 23.5   2.8
LT  /  None 0.8% croton oil 31.5   9.7
For skin sensitization, mice were painted with 100  l hapten. 10 d later, CH was elicited by painting the ears with 10  l hapten. Ear thickness was
measured and the average percent increase in thickness (n   6, FITC; n   8, oxazalone; n   4, croton oil) was determined for each set of mice. FITC
and oxazalone data are representative of four independent experiments. Croton oil responses were not statistically different from each other. For
experiments using TMA, mice were sensitized on the shaved abdomen with 50  l either by subcutaneous (s.c.) injection or skin painting (e.c.). Elicitation
of the footpad was with 20  l TMA presented either subcutaneously or by painting. Footpad swelling is thickness at site of challenge   thickness of
contralateral control. The TMA experiments were performed three times with similar results.
*P   0.005 for values significantly less than LT / /hapten positive control.
‡P   0.01 for values significantly less than LT / /hapten positive control.1230 Contact Hypersensitivity Requires Lymph Nodes
response. Then, we initiated our studies of CH responses by
comparing the ability of LT  /  mice and LT /  mice to
respond to hapten challenge. In LT  /  mice, the CH re-
sponse to FITC was greatly reduced, approaching back-
ground levels (Table II). This result was independent of the
hapten used, as LT  /  mice were also unable to respond
to oxazalone (Table II) and DNFB (Table III).
In experiments using another hapten (TMA), we ob-
served that the delayed type hypersensitivity (DTH) re-
sponse of LT  /  and LT  /  mice to subcutaneous in-
jections were indistinguishable (Table II). This suggested
that dermal APCs were triggering T cell activation despite
the lack of LNs or of LT ligands. We tested if excessive
hapten doses applied to the epidermis would breach epi-
dermal integrity and lead to a mixed epidermal/dermal
CH/DTH response. LT  /  mice sensitized with as much
as 150  l 2% oxazalone failed to respond to subsequent
challenge (Table II). Similarly, LT  /  mice sensitized
with as much as 20  l of 1% DNFB did not respond to
subsequent challenge (data not shown). Thus, LT  / 
mice did not mount a CH response even when excessive
doses of hapten were used for sensitization. Finally, we ex-
amined the ability of LT  /  mice to respond to chemical
irritation using a croton oil assay. The response to irritant
in this model is T cell independent (24). In contrast to the
defect seen in the CH models, the irritant response of
LT  /  mice was similar to wild type (Table II). There-
fore, LT  /  were capable of an epidermal inflammatory
response which does not require T cell activation.
BM-derived Cells from LT  /  Mice Are Capable of Mediat-
ing CH Responses. The initial experiments in LT  / 
mice suggested that the CH response to epidermal antigen
was defective despite normal T cell priming and immune
response to antigens presented within the dermis. To assess
whether the inability of lymphocytes to make surface
LT   or secrete LT  was responsible for the defective CH
response in LT  /  mice, BM cells from LT  /  mice
were transferred into irradiated wild-type mice. Mice were
used in CH experiments 8–12 wk after BM transfer. Such
chimeric mice, which retain a full complement of LNs, had
a slightly attenuated response to the hapten DNFB (Table
III), indicating that LT expression by lymphocytes does not
Table III. BM-derived Cells Are Not Responsible for the Defect in 
CH Response in LT  /  Mice
Experiment Donor Recipient
Priming
dose
Footpad
swelling
%m m
1  /   /  0.5 0.97   0.09
 /  LT  /  0.5 0.13   0.06*
LT  /   /  0.5 0.75   0.07
LT  /  LT  /  0.5 0.08   0.02*
Nonirradiated control  /  0.5 1.14   0.17
LT  /  0.5 0.18   0.06*
 /  0 0.17   0.05*
2  /   /  1.0 0.92   0.27
 /  LT  /  1.0 0.07   0.02*
LT  /   /  1.0 0.52   0.12
LT  /  LT  /  1.0 0.09   0.04*
Nonirradiated control  /  0 0.06   0.01*
Nonirradiated control LT  /  0 0.09   0.02*
Mice were lethally irradiated (1,100 rad) and reconstituted within 4 h
with 2   106 BM cells from the indicated mice. Mature T cells in the
BM cell suspension were depleted using anti-Thy1.2 mAb plus
complement. The CH experiments were performed 6 wk later, using
DNFB as the hapten, and three mice per group. Footpad swelling is
thickness at site of challenge   thickness of contralateral control.
*P   0.0005 for values less than the donor/recipient positive control.
Table IV. LT  /  Mice Treated In Utero with Anti–LT -R to Induce LN Genesis Have a Normal CH Response to Hapten
Percent swelling
Strain
Treatment
in utero LN formed Sensitization Elicitation Expt. 1 Expt. 2 Expt. 3
LT  /  None or Ha4/8 None FITC FITC 14   9* nd 9   7*
LT  /  AF.H6 Brachial, axillary,
mandibular, iliac,
mesenteric, cervical,
sacral
FITC FITC 40   19 37   7 23   7
LT  /  None All FITC FITC 40   13 34   10 25   11
LT  /  None All FITC Vehicle 5   1* 1   4* 1   .4*
For sensitization, mice were painted with 100  l FITC. 10 d later, CH was elicited by painting the ears with10  l FITC. Ear thickness was measured
and the average percent increase in thickness (n   6) was determined for each set of mice. Expt., experiment; nd, not done.
*P   0.005 for values significantly less than LT / /FITC positive control.1231 Rennert et al.
play a dominant role in the CH response. Immunohis-
tochemical analyses showed that no FDCs, germinal cen-
ters, or MZ markers could be detected in the spleen of
these chimeric mice, indicating that LT  expressing cells
were absent as expected (3).
When wild-type BM was transferred into irradiated
LT  /  mice and tested in the DNFB CH model, the chi-
meric mice were unable to respond to DNFB challenge
(Table III). The wild type into LT  /  BM transfer does
not restore LN development, as LN organogenesis is devel-
opmentally regulated (12, 22); however, splenic function is
restored (3). These results show that expression of LT  by
circulating cells is not essential for CH, but rather suggests a
critical role for LNs in the generation of the CH response.
FITC-mediated CH Is Restored in LT  /  Mice that Have
LNs. The BM transfer experiments suggested that LNs
were required for CH responses. To formally address this
hypothesis, we induced LN genesis in LT  /  mice by us-
ing the agonist anti–LT -R mAb AF.H6 to signal LT -R
during development (12). Progeny of litters which received
this maternal transfer treatment were examined for the
presence of LNs, and LT  /  mice from litters demon-
strated to have pLNs (brachial, axillary, mandibular, iliac)
and mucosal LNs (mesenteric, cervical, sacral) (Table IV)
were assayed in the CH model. All mice were examined at
necropsy to confirm which LNs were present. The tran-
sient exposure to the anti–LT -R mAb during gestation
did not alter the lymphoid microenvironment of the spleen
of LT  /  mice, as immunohistochemical examination re-
vealed that these mice still had disrupted MZs, lacked T/B
cell segregation, and had no FDCs (data not shown). The
results showed that LT  /  mice having LNs generated a
CH response that was comparable to the response of
LT  /  mice, whereas the response of LT  /  mice with-
out LNs was grossly impaired (Table IV).
LT  /  Mice that Lack LNs Cannot Respond to Hapten
Challenge. LT  /  mice and LT  /  mice share defects
in LN and PP genesis, spleen and LN cellular organization,
and humoral responses, but differ in regard to the presence
of LT  homotrimers and of mucosa-associated LNs (3). In
contrast to LT  /  mice, LT  /  mice responded at the
same level as LT /  or C57Bl/6 control mice to both
FITC or oxazalone challenge in the CH model (Table V,
and data not shown). Importantly, the LT  /  mice used
for these studies lacked all LNs except mesenteric, sacral,
and cervical, none of which directly drain the sensitized
area of the skin. We next investigated the capacity for CH
responses in LT  /  mice that lacked all LNs.
The original colonies of LT  /  mice retained mLNs,
cervical LNs, and sacral LNs, which was true regardless of
whether the gene deletion was on a pure C57BL/6 or
mixed 129/C57BL/6 backgrounds (15, 16; and unpub-
Table V. The Loss of LNs from LT  /  Mice Results in the Loss of the CH Response to Hapten
Percent swelling
Strain LN found Sensitization Elicitization Expt. 1 Expt. 2 Expt. 3
LT /  All Vehicle FITC nd 3.1   3.2* 2.5   2.9*
LT /  All FITC Vehicle 3.2   3.8* nd 2.3   2.7*
LT /  All FITC FITC 52.2   20 24   9.5 23   11
LT  /  Mucosal FITC FITC 62.2   3.3 29   8.4 43   18
LT  /  None FITC FITC 8.8   2.7* 8.5   4.4*
(n   2)
9.3   6.8*
Mice were painted on the upper trunk with 100  l FITC then rechallenged 10 d later on the ears with 10  l FITC.
Ear thickness was determined and values shown are percent increase. “Mucosal” refers to the presence of one or more mesenteric, cervical, or sacral
LNs. n   6 in each experiment shown, except LT  /  mice, no LNs, in experiment 2 (n   2 as noted). Expt., experiment; nd, not done.
*P   0.005 for values significantly less than LT / /FITC positive control.
Table VI. Balb/c Mice which Selectively Lack Peripheral and mLNs 
Have a Normal CH Response to Hapten whereas Balb/c Mice which 
Lack All LNs Do Not Respond to Hapten Challenge
Percent swelling
LN Sensitization Elicitation Expt. 1 Expt. 2 Expt. 3
All FITC FITC 75   13 62   13 30   6
All FITC Vehicle 0   3* 5   2* nd
All Vehicle FITC nd nd 3   3*
Mucosal LNs‡ FITC FITC 51   12 43   19 25   10
mLNs only§ FITC FITC nd nd 33   4
None FITC FITC nd nd 9   5*
For the CH experiments, the adult progeny were painted with 100  l
FITC then rechallenged 10 d later on the ears with 10  l FITC. Change
in ear thickness was determined. All mice were examined for the
presence of LNs at necropsy. Values shown are percent increase in ear
thickness (n   6).
*P   0.005 for values significantly less than FITC control.
‡Pregnant Balb/c mice received LT -R-Ig and TNF-R55-Ig fusion
proteins, and their progeny developed none or varying numbers of mu-
cosal LNs (see text).
§These mice had 1–3 mLNs only.1232 Contact Hypersensitivity Requires Lymph Nodes
Figure 1. Immunohistochemical characterization of FITC-laden LCs within LNs. (A–E) Immunohistochemical images of LNs taken from mice 24 h
after FITC painting: brachial LNs from LT  /  (A) and LT  /  mice (B). Original magnification:  50. FITC reactivity is present in the subcapsular si-
nus and in the T cell area; counterstaining is PE–anti-B220. mLNs are from Balb/c mice which lack peripheral LNs (C and F), from a Balb/c mouse
which has pLNs (D), and from an LT  /  mouse (E). Original magnification:  100. FITC reactivity is in the T cell area of the Balb/c mLN (C, red1233 Rennert et al.
lished data). The presence of various mucosa-associated
LNs in LT  /  mice versus their absence in LT  /  mice
has been interpreted as evidence for additional signaling
components in the LT system, e.g., via LT  /  or LIGHT
(15). However, a complete lack of mLNs was observed in
up to 25% of the LT  /  mice in three separate colonies
(15, 16; and unpublished data). Furthermore, considerable
variation in the LN content of LT  /  mice was noted in
different colonies with mLNs being present in 5–25% of
LT  /  mice in three separate colonies (13, 14; and un-
published data). Mice lacking mLNs were only rarely ob-
served in the original colony of LT  /  mice (15); how-
ever, after sterile rederivation and housing in our specific
pathogen-free facility, we now find LT  /  mice which
have no LNs (40%), retain only a single mLN or several
mLNs and cervical LNs, (40%), or have all mLNs, sacral
LNs, and cervical LNs (20%). A similar change in pheno-
type has been reported in a separately derived colony of
LT  /  mice (19). It now appears that LN formation is
largely defective in these mice.
To determine if the ability of LT  /  mice to respond
to hapten challenge depended on the presence of LNs,
LT  /  mice were tested in the FITC or oxazalone CH
models then examined at necropsy to determine which
LNs were present. In contrast to LT  /  mice that re-
tained LNs, those without LNs failed to mount a CH re-
sponse to either FITC or oxazalone (Table V, and data not
shown). Strikingly, a single remaining mLN was sufficient
to generate a CH response. In agreement with the BM
transfer and LT  /  studies, these results suggest that the
ability of LT  /  mice to generate a CH response depends
on the presence of LNs.
Hapten-mediated CH Responses Are Blocked in Normal Mice
that Lack All LNs. As the presence of LNs in LT  / 
mice restored the ability to mount a CH response, we next
asked if the loss of LNs from wild-type mice would ablate
the CH response. Using either LT -R-Ig or a combina-
tion of LT -R-Ig and TNF-R55-Ig, we can reproducibly
block the development of only pLNs, or of peripheral and
mucosal LNs, respectively (12). By varying the time at
which dosing with antagonists is initiated, the extent of LN
development can be manipulated (12). Furthermore, one
or two mLNs are occasionally “spared” in some pups
treated with LT -R-Ig and TNF-R55-Ig starting at day 11
of gestation (12). Using these methods we have engineered
normal mice having variable numbers of mLNs, but lacking
all other LNs (Table VI). We tested the immunocompe-
tence of these mice in CH models, and evaluated at
necropsy which LNs were present.
Mice retaining mucosal LNs but no pLNs were capable
of efficient CH responses, whereas mice which lacked all
LNs failed to respond to challenge with either FITC or ox-
azalone (Table VI and data not shown). These results
strongly suggested that the ability of individual mice to re-
spond to hapten challenge was due to the presence of LNs.
The minimal LNs required to support a CH response
was examined using mice from litters given dual treatment
in utero beginning on day 11 of gestation and having pro-
gressively fewer peripheral or mucosal LNs. All mice which
retained a single LN were capable of responding to hapten
challenge whereas those which had no LNs failed to re-
spond to the challenge (Table VI). This was true within lit-
ters having some pups with a single mLN and littermates
having no LNs. Therefore, even a single nondraining LN
was sufficient to enable a CH response.
Trafficking of LCs in LT /  Mice and in Normal Mice Lack-
ing pLNs. As mentioned earlier, immunohistochemical
examination of the skin of wild-type and LT  /  mice had
not revealed any difference in the extent or pattern of LC
staining (unpublished data). However, it was critical to
demonstrate that LCs could traffic from the skin to LNs in
the LT /  mice, as the increase in LC number isolated after
hapten painting correlates with T cell proliferative activity
in the LNs (26). Therefore, various LT /  mice were
painted with FITC, and the draining brachial and axillary
LNs (if present), the mLNs (if present), and the spleen were
harvested 24 h later. Mice painted with vehicle alone had
no FITC reactivity in the draining LNs (data not shown).
Little or no FITC staining was found in the spleens of
painted control, LT  / , or LT  /  mice (data not
shown). FITC reactivity in LNs taken from LT / , LT  / ,
or LT  /  mice 24 h after painting was primarily limited
to the T cell areas and adjacent sinus (Fig. 1, and data not
shown). The source of FITC reactivity in the LNs of
FITC-painted mice was confirmed to be LCs using manual
disruption of LNs followed by metrizamide isolation and
FACS® analyses. LC purity after isolation was  70%, with
the remainder being primarily B cells and T cells. LCs, de-
fined based on large size and complexity, were FITC ,
CD11c , NLDC145 , MHC class II bright, and B7-2
bright (data not shown). From these data we concluded
that the fluorescent staining in LNs detected by immuno-
histochemistry was due to the influx of LCs carrying FITC,
as reported previously (26–31).
These results suggested that LCs could traffic to remain-
ing LNs to trigger T cell activation, and thereby support a
CH reaction upon rechallenge. When pLNs were absent,
FITC reactivity was readily observed in the T cell areas of
the nondraining mLNs (Fig. 1, B–E), whereas little or no
FITC reactivity could be found in the white pulp zones of
the spleen (data not shown). When draining pLNs were
present, FITC reactivity was not observed in nondraining
LNs or in mLNs (Fig. 1 D). Therefore, LCs preferentially
accumulate in the first LNs they encounter, which is nor-
mally the draining LNs, as noted previously (10). When the
draining LNs are absent, LCs can home to any LNs. In
staining is PE–anti-B220; and F, red staining is PE–anti-CD11c). FITC-laden cells are also CD11c , as are resident DCs (F). Trafficking LCs are both
FITC  and CD11c  and so appear yellow. In the LT  /  mouse, FITC reactivity is present in the T cell area, as well as the disrupted B cell areas and
adjacent sinus (E, red staining is PE–anti-B220). T, T cell area; B, B cell area.1234 Contact Hypersensitivity Requires Lymph Nodes
contrast, either LCs do not home to splenic white pulp, or
the density of LCs that reach the spleen is insufficient to
trigger a CH response. To further demonstrate that hapten
specific responses were generated in mLNs but not spleen,
we performed adoptive transfer experiments. Balb/c mice
lacking all pLNs, but retaining mLNs and spleen, were sen-
sitized with oxazalone. 4 d later mLN cells and splenocytes
were isolated and transferred to normal, naive Balb/c mice,
which were then challenged by ear painting with oxaza-
lone. The CH response was measured after 24 h, and the
results (Fig. 2) demonstrate that cells isolated from mLNs,
but not spleen, were capable of adoptively transferring the
capacity for CH to naive recipients. Therefore LN-specific
homing by LCs is essential for the T cell priming underly-
ing the CH response.
Discussion
We have demonstrated that LNs are required to initiate a
CH response by using the LT system to manipulate the de-
velopment of LNs on wild-type and LT-deficient back-
grounds. Our critical finding is that CH can occur in
LT  /  mice in which LNs have been induced to develop,
regardless of the lack of LT  expression by circulating lym-
phocytes. LNs were essential for the CH response to hap-
tens which induce cytokines typical of both Th1- (DNFB)
and Th2- (FITC and oxazalone) dominated responses (30,
31, and references therein). This observation was consistent
in all experimental settings when LT  /  mice and LT  / 
mice with or without LNs were contrasted, and further
supported by the BM transplantation studies using LT  / 
mice. These results are fully consistent with the paradigm
that LNs are a critical site of T cell activation in response to
epidermal antigens.
The earliest modern investigations of CH grew out of
efforts to understand the pathology associated with human
responses to poison ivy, Japanese lacquer, and other sub-
stances which caused contact reactions. Early work focused
on identifying the inducing agents, which led to the dis-
covery of a variety of sensitizing compounds. Some investi-
gators of the period hypothesized that contact sensitization
was due to the diffusion of antigen or conjugates via epi-
dermal channels, whereas others stressed the importance of
passage via lymphatic vessels or the bloodstream (6, and ref-
erences therein). A functional role for the draining LNs was
specifically postulated somewhat later (32), but the anat-
omy of the sensitization reaction remained controversial for
many years, with the mechanistic focus remaining on the
site of sensitization, that is, the skin itself (33, and refer-
ences therein). The relationship between epidermal sensiti-
zation and the lymphatic system became clearer as a under-
standing of lymphocyte and dendritic cell populations
developed, particularly with reference to presence of LCs
in the epidermis (26, 34). Finally, it was determined that
the induction of CH can be blocked by antagonism of var-
ious LC properties: activation, migration to LNs, or ability
to activate T cells (4, 5, 8, 9, 28, 31). Thus, data accumu-
lated over the course of many decades supported the hy-
pothesis that LCs migrated to LNs, which hosted the T
cell–dependent immune response to epidermal antigen,
and therefore the development of CH.
We formally tested the hypothesis that LN structure pro-
vides a critical environment which supports CH responses
by using in utero blockade of the LT -R and TNF-R
pathways to eliminate LNs from wild-type mice. In utero
antagonism of the signaling pathways is transient, and our
previous studies have indicated that although the organo-
genic defects are irreversible, secondary lymphoid architec-
ture, including B cell localization, integrity of splenic MZ
populations, and LN addressin expression, is restored in the
adult progeny (22, 23). Furthermore, we have recently
shown that wild-type mice treated in utero with LT -R-Ig
are capable of antigen-specific T cell responses (35). There-
fore, the simplest model to explain the loss of CH respon-
siveness in wild-type mice lacking LNs is that LNs provide
the proper environment to ensure productive interaction of
LCs with circulating T cells. Furthermore, because LCs do
not appear to access the splenic white pulp, the spleen is in-
capable of compensating for the loss of LNs. Finally, any
other encounter of LCs with potentially responsive T cells
is either very rare or functionally irrelevant (2).
Surprisingly, the CH response can be triggered in LNs
that do not directly drain the site of antigen exposure; in-
stead, any LN within the intact lymphatic network is suffi-
cient to support the required LC/T cell interaction. We
have demonstrated that antigen-bearing LCs traffic to dis-
tant LNs; the route of traffic, however, cannot be deter-
mined from these studies. Lymph typically drains into the
bloodstream via the thoracic and right subclavian ducts. It
Figure 2. mLN cells, but not splenocytes, can adoptively transfer CH
to naive recipients. Balb/c mice having mLNs, but no pLNs, were sensi-
tized with oxazalone. 4 d later cell suspensions of mLN (“LN cells”) and
spleen (“spleen cells”) were harvested and injected intravenously into
normal, naive, recipient mice, which were challenged to induce CH. “ 
control” refers to mLN /pLN  mice which were sensitized and chal-
lenged with oxazalone. “  control” refers to mLN cells isolated from
nonsensitized mice. *P   0.001 for values significantly less than the posi-
tive control (n   6).1235 Rennert et al.
is possible that antigen-bearing LCs are carried by normal
circulation to tissue beds and then drain to remaining LNs
via afferent lymphatics; however, it is also possible that they
are entering LNs directly from the bloodstream by crossing
HEVs. Regardless of the route of traffic, the adoptive trans-
fer experiments clearly show that T cell priming to hapten
has occurred in the mLNs, but not the spleen, of pLN–
deficient mice.
Several recent studies have addressed the role of differ-
ent secondary lymphoid compartments in mediating im-
mune responsiveness. An essential role for LNs in antiviral
immunity was suggested by studies using the LN-deficient
alymphoplastic (aly/aly) mice. Aly mice were unable to
control LCMV infections, and BM transfer studies sup-
ported the hypothesis that the impaired antiviral response
was due to the lack of LNs (36). This hypothesis was sup-
ported by the observation that the Hox11 /  mice, which
lack the spleen but have LNs, retained a normal antiviral
response (36). LT  /  mice also had a defective antiviral
responses, with significantly delayed kinetics of lympho-
cytic choriomeningitis virus (LCMV) clearance (37). The
LT  /  mice used in this LCMV study retained mucosal
LNs; moreover, it appeared that the LT -dependent de-
fect was manifested because it caused disrupted splenic or-
ganization, particularly of the MZ. However, this conclu-
sion is at odds with the Hox11 /  mouse study. In
addition, some antiviral responses can be manipulated in a
manner which may be independent of the status of sec-
ondary lymphoid tissue (38). Wild-type mice lacking LNs
and/or spleen should provide a useful model to study anti-
viral responses and address these issues.
Recently, it was demonstrated that an immune response
to intradermally administered tetanus toxoid in an immu-
nocompetent SCID-hu model required an engrafted hu-
man fetal LNs (39), suggesting the mouse spleen could not
trigger an immune response in this setting. Another recent
study demonstrated functional overlap of spleen and LN re-
sponses, in which transplant rejection could be mediated in
the absence of LNs (and PPs), or spleen, but not in the ab-
sence of all secondary lymphoid tissue (40). Functional
overlap of mLNs and PPs for gut immune responses was
also recently demonstrated (35). In contrast, skin transplant
rejection required LNs, but not spleen (40), a requirement
similar to that described in this study. Finally, the spleen is
known to be essential for immunity to encapsulated bacteria
(41), and the splenic MZ compartment has recently been
shown to be critical for the immune response to T cell–inde-
pendent antigens (42). These observations suggest that each
secondary lymphoid compartment has evolved, at least in
part, to respond to specific types of antigen presentation.
Our results invite a reinterpretation of several other stud-
ies of immune responsiveness in LT /  mice. For example,
LT  /  mice and LT  /  mice responded differently to
myelin oligodendrocyte glycoprotein (MOG) peptide im-
munization in a model of experimental autoimmune en-
cephalomyelitis (EAE) development, suggesting that LT 
was required for this response (43). However, a second
study suggested that genetic background, immune incom-
petence, and/or altered lymphoid structure in LT  / 
mice accounted for their failure to respond in an EAE
model (44). This hypothesis was supported by results dem-
onstrating that robust disease developed upon MOG pep-
tide immunization after transfer of LT  /  BM cells to re-
combination activating gene (RAG) /  recipients. These
observations suggest that it is difficult to compare LT  / 
mice, LT  /  mice, or TNF /  mice in such disease mod-
els without taking into account additional variables such as
LN status, cellular organization, and other developmental
defects, e.g., on hematopoiesis (45). The data presented
here support the interpretation that the LT  /  and LT  / 
mice are relatively similar in immune competence, and
differences in their disease susceptibility stem from the
presence and absence of LNs. Recent work suggesting a
critical role for draining LNs in diabetes (46) indicates that
there will be similar complexity in interpreting the role of
the LT axis, separate from the role of LNs, in several dis-
ease models.
The fact that LT ligands did not play a more dominant
role in the CH response is perhaps surprising in light of re-
cent data. LT  /  mice have reduced numbers of resident
DCs within secondary lymphoid organs, probably due to
reduced expression of chemokines, including secondary
lymphoid tissue chemokine (SLC; CCL21) and EBV-
induced molecule 1 ligand chemokine (ELC; CCL19)
(47–50). This reduction in resident DC number reflects
defective traffic into the T cell zones of LNs, rather than
the failure of DCs to develop (48). The reduction in resi-
dent DC number may be partially offset by the loss of LNs
and PPs in LT-deficient or wild-type mice, such that DCs
may accumulate in tissues such as spleen or remaining LNs;
however, this has not been investigated. Certainly the lo-
calization of DCs, and of LCs which reach LNs in LT-defi-
cient mice appears disrupted, being less restricted than nor-
mal to the T cell zone.
The concept of “T zone tropism” (1) is well illustrated
by the paucity of LN T cells (plt) mouse, in which both T
cells and DCs fail to migrate into the T cell zone of spleen
and mLNs, due to the lack of expression of SLC and ELC
in LNs (51, 52). When plt mice were challenged on the
skin with hapten, 75% fewer LCs accumulated in draining
LNs than in wild-type mice (51). Therefore, LCs traffic
into LNs is also influenced by expression of these chemo-
kines. However, CH responses in these mice appeared nor-
mal, and, although the site of priming was not identified,
labeled epidermal DCs could not be found in the spleen
(53). It does appear that supraoptimal doses of hapten were
used in this study (54), which may complicate interpreta-
tion of the CH result. Indeed, knockout of the SLC/ELC
receptor CC chemokine receptor (CCR)7 produced
somewhat different results, as the CCR7 /  mice had es-
sentially no T cells or DCs in LNs and did not respond to
hapten challenge in the FITC CH model (29). SLC was
absent and ELC expression was reduced by 75% in the
spleen of LT  /  mice (49), and it may be the continued
expression of ELC in LT /  mice that supports sufficient
accumulation of LCs into LNs to support the CH response.1236 Contact Hypersensitivity Requires Lymph Nodes
Alternatively, unknown mechanisms may be operating.
Given that multiple genes for SLC have been identified,
and that there is some evidence for differential expression
of SLC and ELC in secondary lymphoid organs, the epi-
dermis, and lymphatics, the roles of SLC and ELC in the
traffic of LCs and DCs into secondary lymphoid organs will
require additional investigation (52, 55, 56).
It has been demonstrated that LCs form a continuous re-
ticular barrier which has evolved to trap epidermal antigens
(57). Our results highlight not only the critical role that
LCs play in mediating epidermal immune responses, but
also the essential nature of LNs in supporting LC-driven T
cell activation. The mechanisms which allow preferential
LC traffic to distant LNs, but not splenic white pulp, are
not understood, but may involve specific chemokine re-
sponsiveness. The reliance on LNs appears to be unique to
LCs residing in the epidermal compartment, as our results
indicate that subcutaneous hapten injection results in an in-
tact hypersensitivity response in LT  /  mice (Table II).
This suggests that presentation of subepidermal antigen
does not rely solely on LNs, possibly because antigen
which reaches the dermal layer will encounter additional
populations of APCs (58). Our model predicts that dermal
APCs have trafficking properties that allow access to other
lymphoid compartments such as spleen in addition to LNs.
Indeed, such a mechanism was recently proposed to ex-
plain the enhanced response to subcutaneously presented
antigen in the plt mouse, whereby the T cell response
shifted from draining LNs to the spleen (53).
Our studies have conclusively identified an essential role
for LNs in a T cell–dependent immune response. Further-
more, we have demonstrated that LCs specifically home to
LNs, and will traffic until a LN is encountered, bypassing
the spleen. This specific trafficking of LCs to LNs com-
prises a unique and critical component of the secondary
lymphoid system, and illustrates the importance of func-
tional anatomy for immune responses. The signals that sup-
port LC access to LNs will be a important area for future
study, and may yield therapeutic targets to allow highly
specific intervention in CH and other disorders.
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